Follow the Longboard Pharmaceuticals, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €2.2bn. The latest transaction was disclosed on 2 December 2024 (U). Among the most active insiders: Kaye Randall. All data is openly available.
11
Insider Decl.
n/a
Thresholds
€2,281
1 ops.
Buy Volume
€89m
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Longboard Pharmaceuticals, Inc. Strong Buy (bullish), based on 12 analysts. Average price target: US$59.30.
30Σ signal
Buys €2,281€89m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
3,978,540 shares@ US$24.25100.0% of flowVoting Common StockSEC:0000078003-24-000012:0
11 of 11 declarations
Acerca de Longboard Pharmaceuticals, Inc.
Longboard Pharmaceuticals, Inc. es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para trastornos neurológicos. Cotiza en NASDAQ bajo el símbolo LBPH.